Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F11%3A10104743" target="_blank" >RIV/00216208:11140/11:10104743 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.3851/IMP1879" target="_blank" >http://dx.doi.org/10.3851/IMP1879</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3851/IMP1879" target="_blank" >10.3851/IMP1879</a>
Alternative languages
Result language
angličtina
Original language name
Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients
Original language description
Adult renal transplant recipients were assigned to 3-month prophylaxis with either valganciclovir (900mg q.d., n=19) or valacyclovir (2g q.i.d., n=17) as part of an ongoing randomized trial. Subsets of lymphocytes, lymphocyte proliferation and/or cytokine production after in vitro mitogen stimulation were evaluated at the end of prophylaxis and one month after withdrawal of antiviral drugs. Lymphocyte proliferation was significantly decreased both after phytohemagglutinine (25+-15 vs. 32+-18%, P=0.025)and concanavalin A stimulation (17+-9 vs. 25+-16%, P=0.011) during valganciclovir, but not valacyclovir therapy. Moreover, a lower activated T cell count (CD3+HLA-DR+ cells) was noted in valganciclovir-treated patients (13+-10 vs. 17+-12% of total CD3+ Tcells, P=0.005). Conclusions: Valganciclovir suppresses lymphocyte proliferation and activation in patients after renal transplantation.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FJ - Surgery including transplantology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Antiviral Therapy
ISSN
1359-6535
e-ISSN
—
Volume of the periodical
16
Issue of the periodical within the volume
8
Country of publishing house
GB - UNITED KINGDOM
Number of pages
9
Pages from-to
1227-1235
UT code for WoS article
—
EID of the result in the Scopus database
—